Latest filingSep 10, 2026Most recent Form 4
HEPA
Hepion Pharmaceuticals, Inc.
OTCHealthcarePharmaceutical Preparations
Insider activity for last month from 08/11 to 09/11. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$08 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period8transactions
- A · Grants / awards · dominant8 · 100%
Activity by reported role
A joint filing can contribute to multiple roles9transactions
- Director · dominant4 · 44%
- CD1 · 11%
- CHAIR1 · 11%
- COO1 · 11%
- IC1 · 11%
- VP1 · 11%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (8)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeStetz Gary S. IIStock Options · Direct
299,000Aug 19, 2026
Appajosyula SireeshStock Options · Direct
1,345,500Aug 19, 2026
Liddy James GordonStock Options · Direct
299,000Aug 19, 2026
Fisher DaninaStock Options · Direct
299,000Aug 19, 2026
LoPriore ChaseStock Options · Direct
1,345,500Aug 19, 2026
LoPriore Vincent SStock Options · Direct
1,345,500Aug 19, 2026
Stetz Gary S.Stock Options · Direct
1,345,500Aug 19, 2026
Purcell Michael J.Stock Options · Direct
299,000Aug 19, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 11 → Sep 11
LessMore
Top insiders
By absolute net value across the selected period- PJ+$0
- SS+$0
- LS+$0
- LC+$0
- FD+$0
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
HEPA transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| HEPA | Purcell Michael J. | DIR | grant | 299k | $0 | A | — | 0.0% | 09/10 | 08/19 |
| HEPA | Stetz Gary S. | IC | grant | 1.34M | $0 | A | 0.0% | 08/21 | 08/19 | |
| HEPA | LoPriore Vincent S | CHAIR | grant | 1.34M | $0 | A | 0.0% | 08/21 | 08/19 | |
| HEPA | LoPriore Chase | VPCD | grant | 1.34M | $0 | A | 0.0% | 08/21 | 08/19 | |
| HEPA | Fisher Danina | DIR | grant | 299k | $0 | A | 0.0% | 08/21 | 08/19 | |
| HEPA | Liddy James Gordon | DIR | grant | 299k | $0 | A | 0.0% | 08/21 | 08/19 | |
| HEPA | Appajosyula Sireesh | COO | grant | 1.34M | $0 | A | 0.0% | 08/21 | 08/19 | |
| HEPA | Stetz Gary S. II | DIR | grant | 299k | $0 | A | 0.0% | 08/21 | 08/19 |
Hepion Pharmaceuticals, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Hepion Pharmaceuticals, Inc.?
Purcell Michael J., Stetz Gary S., LoPriore Vincent S, LoPriore Chase, Fisher Danina, Liddy James Gordon, Appajosyula Sireesh, Stetz Gary S. II.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.